Navigation Links
Colorectal Cancer Screening Gets Special Look in AJMC Papers
Date:8/24/2015

A trio of papers in The American Journal of Managed Care examining the usefulness of widespread screening for colorectal cancer (CRC) finds the policy is cost-effective, but there might be ways to limit unnecessary tests.

The Affordable Care Act (ACA) called for eliminating cost sharing for colorectal cancer screening, but elements of the law that require payment for diagnostic tests—if symptoms are present—mean that some patients face out-of-pocket costs anyway. Thus, uptake of this tool has not been as widespread as some hoped. These recently published papers look at aspects of the ACA requirement from policy and payer perspectives:

  •     “The Value of Colonoscopic Cancer Screening of Adults Aged 50 to 64 Years,” led by Kathryn Fitch, RN, MEd, found that increasing uptake of screening from 50% to 100% would increase screening costs for a commercial payer $3 per member per month while decreasing CRC treatment costs $1 per month (in 2013 dollars). Fitch et al calculated the cost per life-year saved at $12,000, which is lower than cervical or breast cancer and comparable to lung screening.
  •     In “Pilot of Decision Support to Individualize Colorectal Cancer Screening Recommendations,” authors led by Amy R. Schwartz, MD, examine the use of a decision support system, facilitated by electronic medical records, that ensures the right patients are screened. This method balances what the authors called the potential harms of the test itself with longer-term benefits.
  •     In “Colorectal Cancer Screening in the 21st Century: Where Do We Go From Here?” Jennifer K. Maratt, MD, and Sameer D. Saini, MD, MS, examine the findings of both Schwartz and Fitch, as well as other aspects of the issue, noting that some payers may balk at funding screenings for the 50 to 64-year-old age group if they believe the savings are really going to Medicare. The value of CRC screening is “indisputable,” they write, and the challenge is ensuring that the right patients are screened, with the goal of moving to a 70% rate by 2020.

About the Journals and AJMC.com

The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. AJMC.com distributes healthcare news to leading stakeholders across a variety of platforms. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.

CONTACT:     Nicole Beagin (609) 716-7777 x 131
        nbeagin(AT)ajmc.com
        http://www.ajmc.com

Read the full story at http://www.prweb.com/releases/2015/08/prweb12922158.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Cancer-Fighting and Aging-Fighting Scientists Announce Joint Discovery in the War against Colorectal Cancer
2. ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period
3. PCC Issue Brief Discusses Rise of Colorectal Cancer in Young Adults
4. Vegetarian Diet Linked to Lower Risk of Colorectal Cancers in JAMA Internal Medicine Article
5. Tumor Location in Colorectal Cancer May Influence Survival
6. Diet Doc Announces Diet Plans for Men Geared Toward Attacking Dangerous Belly Fat Leading to a Reduced Risk of Colorectal Cancer and Other Diseases
7. US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com
8. Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com
9. TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com
10. Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com
11. Asia-Pacific Colorectal Cancer Therapeutics Market worth $1.9 billion by 2020 in New Research Report Available at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... Plano, Texas (PRWEB) , ... May 26, 2017 , ... ... Cord Stimulation System, a powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita ... , “We are pleased to be the first in Arkansas to introduce the ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... Illinois (PRWEB) , ... May 26, 2017 , ... Silver ... The community, which is located on more than four acres of land at 5620 ... independence. , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: ... FAMILY-Our Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... used to say, he is "panther quick and leather tough." His love for others ...
(Date:5/26/2017)... ... ... Water damage to the flooring of several classrooms at The Fort Lee Elementary ... number of critical issues to address before students could return to classes. , First, ... no disruption to class schedules. Second, the project had to comply with New Jersey ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a privately-held ... and developing novel compounds to treat Parkinson,s disease (PD), has ... is a Phase 1/2a randomized, controlled, multicenter study involving patients ... will enroll 50 patients over a 9-to-12-month period. The first ... 10 patients with PD. Participating sites include Denver ...
Breaking Medicine Technology: